Monkeypox cases prompt governments to order vaccine supply
Imvanex is a non-replicating smallpox vaccine developed in collaboration with the US government - News - PharmaTimes
Stay updated with breaking news from Accine . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Imvanex is a non-replicating smallpox vaccine developed in collaboration with the US government - News - PharmaTimes
The head of the World Health Organisation said that the pandemic is not over, cautioning that the cases are on the rise in 110 countries and are being driven mainly by two fast-spreading Omicron sub-variants.
The joint aim of the companies was to provide vaccines to vulnerable communities - News - PharmaTimes
A contract has been signed for almost 100,000 doses of monkeypox vaccine Europe-wide, of which Poland has sought 1,100 doses for medical personnel dealing with patients, the health minister announced on Monday.
Government advisory panel Standing Technical Sub Committee (STSC) of the National Technical Advisory Group on Immunization (NTAGI) has recommended reducing the time period between the second dose and precaution dose of the vaccine against the Coronavirus infection, from nine months to six months, for every individual above the age of 18 years, sources said on Thursday.